The clinical relevance of medication safety advices for drugs in liver cirrhosis and implementation in clinical decision support in pharmacy practice

• In: Oral presentation on Tuesday, 12 September 2017, 14:30-17:30
• At: Seoul (South Korea) (2017)
• Type: Presentation
• By: BORGSTEEDE, Sander (Health Base, Medication Safety and Information Systems, Houten, Netherlands)
• Co-author(s): Rianne Weersink
  Margriet Bouma
  David Burger
  Joost Drenth
  Froukje Harkes-Idzinga
  Nicole Hunfeld
  Margje Monster-Simons
  Sandra van Putten
  Herold Metselaar
  Katja Taxis
  Sander Borgsteede
  
• Abstract:

  Methods

  We combined literature review with assessment by an expert panel. Drugs were classified in one of the categories: safe; no additional risks known; additional risks known; unsafe; and unknown. Recommendations were categorized by the severity of cirrhosis. An advice was considered clinically relevant if action by a prescriber or pharmacist

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login